We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Quantitative, High-Resolution T1 Rho MRI Mapping Scan Reveals Brain Differences in Bipolar Disorder

By MedImaging International staff writers
Posted on 28 Jan 2015
Print article
Image: Using an MRI technique that is sensitive to certain byproducts of cell metabolism, including levels of glucose and acidity, University of Iowa researchers discovered previously unrecognized differences in the brains of patients with bipolar disorder. The T1rho MRI scans showed brain regions of elevated signal in the 15 participants with bipolar disorder compared to the 25 participants who did not have bipolar disorder. The primary regions of difference are the cerebral white matter (yellow) and the cerebellum (red) (Photo courtesy of the University of Iowa).
Image: Using an MRI technique that is sensitive to certain byproducts of cell metabolism, including levels of glucose and acidity, University of Iowa researchers discovered previously unrecognized differences in the brains of patients with bipolar disorder. The T1rho MRI scans showed brain regions of elevated signal in the 15 participants with bipolar disorder compared to the 25 participants who did not have bipolar disorder. The primary regions of difference are the cerebral white matter (yellow) and the cerebellum (red) (Photo courtesy of the University of Iowa).
Using a different sort of magnetic resonance imaging (MRI) technology, researchers have discovered previously unrecognized differences in the brains of patients with bipolar disorder. In particular, the study revealed differences in the white matter of patients’ brains and in the cerebellum, an area of the brain not previously linked with the disorder.

Interestingly, the cerebellar differences were not present in patients taking lithium, the most typically used treatment for bipolar disorder. “This imaging technique appears to be sensitive to things that just have not been imaged effectively before. So it’s really providing a new picture and new insight into the composition and function of the brain [in bipolar disease],” said John Wemmie, MD, PhD, University of Iowa (UI; Iowa City, USA) professor of psychiatry, and senior study author. The findings were published January 6, 2015, in the journal Molecular Psychiatry.

Bipolar disorder affects about 1% of the population. In spite of being comparatively common, scientists do not have a good determination of what causes this psychiatric condition, which is characterized by sudden mood shifts from normal to depressed or to an abnormally elevated or “manic” mood state. The study examined 15 patients with bipolar disorder and 25 control subjects matched for age and gender. The bipolar patients were all in normal (euthymic) mood state during the study.

The UI researchers imaged the study participants’ brains using an MRI strategy known as quantitative high-resolution T1 rho mapping, which is sensitive to specific byproducts of cell metabolism, including levels of glucose and acidity in the brain. Compared to the brains of people without bipolar disorder, the investigators discovered that the MRI signal was raised in the cerebral white matter and the cerebellar region of patients affected by bipolar disorder. The elevated signal may be due to either a reduction in pH or a reduction in glucose concentration—both factors affected by cell metabolism.

Previous research has suggested that abnormal cell metabolism may play a role in bipolar disorder. However, investigating metabolic abnormalities in the brain has been encumbered by the lack of good imaging strategies. Available techniques are slow, low-resolution, and require researchers to identify the region of interest at the beginning of the study. By contrast, the new imaging approach can rapidly acquire a high-resolution image of the whole brain. The study is the first time this MRI technique has been used to study a psychiatric disease.

One reason researchers did not recognize that the cerebellum might be important in bipolar disorder, is because no one chose to search there, according to Casey Johnson, PhD, a UI postdoctoral researcher, and first author on the study. “Our study was essentially exploratory. We didn’t know what we would find. Most of the bipolar disorder research has found differences in the frontal region of the brain. We found focal differences in the cerebellum, which is a region that hasn't really been highlighted in the bipolar literature before.”

Spurred on by the finding, Drs. Johnson and Wemmie conducted a widespread search of the scientific literature on bipolar disorder and began to locate bits of evidence that suggested that the cerebellum may function abnormally in bipolar disorder and that lithium might potentially target the cerebellum and alter glucose levels in this brain region. “Our paper, with this new technique, starts to bring all these pieces of evidence together for the first time,” Dr. Johnson noted.

Dr. Wemmie hopes that the new clues provided by the T1 rho imaging might help to better understand the abnormalities that underlie bipolar disease and lead to enhanced ways to diagnose and treat this problem. Even though lithium can be an effective mood stabilizer for people with bipolar disorder, it causes many disagreeable side effects for patients.

“If lithium’s effect on the cerebellum is the key to its effectiveness as a mood stabilizer, then a more targeted treatment that causes the same change in the cerebellum without affecting other systems might be a better treatment for patients with bipolar disorder,” Dr. Wemmie said.

Related Links:

University of Iowa


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Digital Radiography Acquisition Software
VXvue with PureImpact
Crossover Angiography System
Trinias C16/C12/F12 Unity Smart Edition
X-Ray Meter
Cobia SENSE

Print article

Channels

Ultrasound

view channel
Image: Structure of the proposed transparent ultrasound transducer and its optical transmittance (Photo courtesy of POSTECH)

Ultrasensitive Broadband Transparent Ultrasound Transducer Enhances Medical Diagnosis

The ultrasound-photoacoustic dual-modal imaging system combines molecular imaging contrast with ultrasound imaging. It can display molecular and structural details inside the body in real time without... Read more

Nuclear Medicine

view channel
Image: PET/CT of a 60-year-old male patient with clinical suspicion of lung cancer (Photo courtesy of EJNMMI Physics)

Early 30-Minute Dynamic FDG-PET Acquisition Could Halve Lung Scan Times

F-18 FDG-PET scans are a way to look inside the body using a special dye, and these scans can be either static or dynamic. Static scans happen 60 minutes after the dye is administered into the body, showing... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: The acquisition will expand IBA’s medical imaging quality assurance offering (Photo courtesy of Radcal)

IBA Acquires Radcal to Expand Medical Imaging Quality Assurance Offering

Ion Beam Applications S.A. (IBA, Louvain-La-Neuve, Belgium), the global leader in particle accelerator technology and a world-leading provider of dosimetry and quality assurance (QA) solutions, has entered... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.